Drugs / AZ6244
last change Apr 2014 re-read 3 minutes ago

AZ6244

Developed for
breast cancer
Investigated by
University of Miami

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT01313039 Feb 2011 → Apr 2014 breast cancer University of Miami Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AZ6244 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01313039 ↗
Route Oral “orally twice per day” NCT01313039 ↗